Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Misincorporation signatures for detecting modifications in mRNA: Not as simple as it sounds.

Sas-Chen A, Schwartz S.

Methods. 2019 Mar 1;156:53-59. doi: 10.1016/j.ymeth.2018.10.011. Epub 2018 Oct 23. Review.

PMID:
30359724
2.

A Chemical Signature for Cytidine Acetylation in RNA.

Thomas JM, Briney CA, Nance KD, Lopez JE, Thorpe AL, Fox SD, Bortolin-Cavaille ML, Sas-Chen A, Arango D, Oberdoerffer S, Cavaille J, Andresson T, Meier JL.

J Am Chem Soc. 2018 Oct 10;140(40):12667-12670. doi: 10.1021/jacs.8b06636. Epub 2018 Sep 25.

PMID:
30252461
3.

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.

Roth L, Srivastava S, Lindzen M, Sas-Chen A, Sheffer M, Lauriola M, Enuka Y, Noronha A, Mancini M, Lavi S, Tarcic G, Pines G, Nevo N, Heyman O, Ziv T, Rueda OM, Gnocchi D, Pikarsky E, Admon A, Caldas C, Yarden Y.

Sci Signal. 2018 Jan 30;11(515). pii: eaan0949. doi: 10.1126/scisignal.aan0949.

PMID:
29382783
4.

The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution.

Safra M, Sas-Chen A, Nir R, Winkler R, Nachshon A, Bar-Yaacov D, Erlacher M, Rossmanith W, Stern-Ginossar N, Schwartz S.

Nature. 2017 Nov 9;551(7679):251-255. doi: 10.1038/nature24456. Epub 2017 Oct 25.

PMID:
29072297
5.

Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone.

Enuka Y, Feldman ME, Chowdhury A, Srivastava S, Lindzen M, Sas-Chen A, Massart R, Cheishvili D, Suderman MJ, Zaltsman Y, Mazza CA, Shukla K, Körner C, Furth N, Lauriola M, Oren M, Wiemann S, Szyf M, Yarden Y.

Nucleic Acids Res. 2017 Dec 15;45(22):12681-12699. doi: 10.1093/nar/gkx865.

6.

The short and the long: non-coding RNAs and growth factors in cancer progression.

Sas-Chen A, Srivastava S, Yarden Y.

Biochem Soc Trans. 2017 Feb 8;45(1):51-64. doi: 10.1042/BST20160131. Review.

PMID:
28202659
7.

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.

Sas-Chen A, Aure MR, Leibovich L, Carvalho S, Enuka Y, Körner C, Polycarpou-Schwarz M, Lavi S, Nevo N, Kuznetsov Y, Yuan J, Azuaje F; Oslo Breast Cancer Research Consortium (OSBREAC)SauerTorillGeislerJürgenHofvindSolveigBathenTone FBorgenElinEngebråtenOlavFodstadØysteinGarredØysteinGeitvikGry AarumKåresenRolfNaumeBjørnMælandsmoGunhild MariRussnesHege GSchlichtingEllenSørlieThereseLingjærdeOle ChristianSahlbergKristine KleiviSkjervenHelle KristineFritzmanBritt, Ulitsky I, Diederichs S, Wiemann S, Yakhini Z, Kristensen VN, Børresen-Dale AL, Yarden Y.

EMBO Mol Med. 2016 Sep 1;8(9):1052-64. doi: 10.15252/emmm.201606198. Print 2016 Sep.

8.

Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor.

Enuka Y, Lauriola M, Feldman ME, Sas-Chen A, Ulitsky I, Yarden Y.

Nucleic Acids Res. 2016 Feb 18;44(3):1370-83. doi: 10.1093/nar/gkv1367. Epub 2015 Dec 10.

9.

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression.

Kedmi M, Sas-Chen A, Yarden Y.

J Clin Med. 2015 Aug 13;4(8):1578-99. doi: 10.3390/jcm4081578. Review.

10.

Tumor suppressor microRNAs: a novel non-coding alliance against cancer.

Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y.

FEBS Lett. 2014 Aug 19;588(16):2639-52. doi: 10.1016/j.febslet.2014.03.033. Epub 2014 Mar 26. Review.

11.

A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Sas-Chen A, Avraham R, Yarden Y.

J Mammary Gland Biol Neoplasia. 2012 Mar;17(1):3-14. doi: 10.1007/s10911-012-9243-7. Epub 2012 Feb 12.

PMID:
22327345
12.

Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M, Shema E, Lidor-Nili E, Jacob-Hirsch J, Amariglio N, Lu Y, Mills GB, Rechavi G, Oren M, Domany E, Yarden Y.

Mol Cell. 2011 May 20;42(4):524-35. doi: 10.1016/j.molcel.2011.04.017.

13.

EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Børresen-Dale AL, Pilpel Y, Yakhini Z, Segal E, Yarden Y.

Sci Signal. 2010 Jun 1;3(124):ra43. doi: 10.1126/scisignal.2000876.

Supplemental Content

Loading ...
Support Center